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Abstract
The tear  lm consists of mucus and aqueous phase produced by the Goblet cells and tear glands and overlaying 
oily layer which is result of the function of Meibomian glands. The tear  lm in Dry eye syndrome is damaged 
either through tear de  ciency or through its excessive evaporation. It is considered that the Meibomian gland 
dysfunction is the main reason for Dry eye disease and can result in tear  lm instability, damage of the epithelial 
surface cells, chronic blepharitis, subjective discomfort, contact lenses intolerance and others.
Aim of the current study is the investigation of Meibomian glands in patients of different ages by determination 
of the percent Meibomian gland loss (MGL) for the upper and lower eyelid and the correlation analysis between 
MGL and non-invasive tear break up time (NIBUT).
Materials and methods: The Meibomian gland loss and NIBUT were determined by the corneal Keratograph 
Oculus 5m. 285 eyes were included of patients ranging from 20 to 90 years of age. The meibographic images 
were subsequently analyzed with Image J software. The statistical analysis regarding Pearson correlation, linear 
regression and ANOVA was performed with IBM SPSS v.19.0.0
Results and conclusions: A weak but statistically signi  cant correlation was determined between Meibomian 
glands loss and the non-invasive tear break up time. The patients’ age turns out to be the most important factor, 
while the gender is of no such signi  cance. Besides a difference was estimated between the percent of lower and 
upper eyelid Meibomian gland loss although there is a correlation between them.
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 NIBUT (s) MGL-  (%) MGL-  (%) MGL-  (%) 
20-35 16.20 ± 7.03 15.99 ± 14.04 35.53 ± 18.52 25.76 ± 13.16 
36-50 14.55 ± 6.99 16.21 ± 8.30 35.23 ± 16.14 25.74 ± 10.44 
51-65 12.65 ± 6.72 31.01 ± 14.61 43.36 ± 18.30 37.18 ± 13.16 
66-90 12.55 ± 7.11 33.82 ± 18.24 46.47 ± 16.92 40.15 ± 13.92 
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